Indee Labs

Indee Labs

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

Edit ID  7114869 

Ryan Pawell"team and vortex shedding clarification"
Ryan Pawell edited on 21 Sep, 2018
Edits made to:
Article (+169 characters)
People (+6 rows) (+14 cells) (+155 characters)

The core technology, microfluidic vortex shedding (μVS), uses a microscopic fluid dynamics phenomenon based on vortex shedding to hydrodynamically porate the cell membrane allowing for the deliberate introduction of genetic material to human primary immune cells. Vortex shedding is not a new phenomenon. It can be observed as water flows past boulders in rivers while also being seen as clouds drift over mountains.


In July 2017, Indee Labs closed USD$1.3M in accelerator and angel financing from SOSV, IndieBio, Jude Gomila, Shaun Maguire, Y Combinator and Jaffray Woodriff (executed by his family office, Felton Group, LLC) among others.


Related Golden topics

Adrian Lievano


Julyana Acevado


Justin Jarrell


Katherine Lau


Ryan Pawell


Taylor Murphy

VP, Operations

Warren McKenzie

CEO, Australia

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.